Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2161.50 -7.60 (-0.35%) | NSE 2163.20 -5.90 (-0.27%) | Trade | Add

BSE Live

Apr 10, 16:01

2161.50 -7.60 (-0.35%)

Volume

AVERAGE VOLUME

5-Day

44,183

10-Day

39,965

30-Day

29,852

28,256

NSE Live

Apr 10, 15:59

2163.20 -5.90 (-0.27%)

Volume

AVERAGE VOLUME

5-Day

619,539

10-Day

703,858

30-Day

630,932

669,385

Financials

Print/Copy to Excel : Go

Cash Flow of Glenmark Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	2,154.02	7,000.75	1,571.87	2,337.45	1,943.76
Net CashFlow From Operating Activities	588.80	-495.45	1,474.06	1,216.07	1,243.42
Net Cash Used In Investing Activities	-489.52	3,197.19	-431.47	-896.92	-1,235.23
Net Cash Used From Financing Activities	-95.41	-2,666.45	-978.50	-305.12	-80.79
Foreign Exchange Gains / Losses	-0.38	-0.02	-0.05	-0.10	0.04
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	3.49	35.27	64.05	13.93	-72.57
Cash And Cash Equivalents Begin of Year	127.96	92.70	28.65	14.72	87.29
Cash And Cash Equivalents End Of Year	131.45	127.96	92.70	28.65	14.72